SciELO - Scientific Electronic Library Online

 
vol.26 issue3Adaptation period caracteristics in high - altitude newbornClinical and serological findings for atypical respiratory infections in asthmatic children in Grau Emergency Hospital, EsSalud, 2007 author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Acta Médica Peruana

On-line version ISSN 1728-5917

Abstract

QUISPE-MAURICIO, Angel et al. Cytotoxic effect of Annona cherimola seeds on cell cultures of cervical and breast cancer and chronic myeloid leukemia.. Acta méd. peruana [online]. 2009, vol.26, n.3, pp.156-161. ISSN 1728-5917.

Introduction: Diverse natural products of the Annona genus has been used in the treatment of the cancer. Annona cherimola has diverse pure compounds of its seeds and stems that have demonstrated antitumor activity against nasopharyngeal carcinoma.   Objective: To determine the cytotoxic effect of the Annona cherimola seed extract on the cell lines MCF-7 (Human breast adenocarcinoma), ME-180(epidermal carcinoma of the cervix), K562 (chronic myeloid leukemia) and 3T3 (normal mouse fibroblasts).   Materials and methods: The lines MCF-7, ME-180, K 562 and 3T3, were exposed to four concentrations of the Annona cherimola seed ethanolic extract (0.125, 0.031, 0.008, 0.002mg/mL), also to different concentrations of 5-fluorouracil (5-FU) (0.01563, 0.00391, 0.00098, 0.00024mg/mL) and Cisplatin (0.00250, 0.00063, 0.00016, 0.00004mg/ mL) which were used as a positive controls. Percentage growth was assessed after 48 hours. The growth inhibitory concentration 50 (CI50) was determined using linear regression analysis; also we obtained the coefficients of determination r2 using Microsoft Office Excel 2007. Finally the Selectivity Index of each sample was determined.   Results: The CI50 in μg/mL of the Annona cherimola seed ethanolic extracts were 9.4(r2 = 0.96) for MCF-7; 6.6(r2 = 0.99) for ME-180; 2.2 (r2 = 0.96) for K562 and 29.5(r2 = 0.98) for 3T3. The CI50 of 5-FU were 3.4(r2 = 0.95) for MCF-7; 3.8(r2 = 0.96) for K562 and 0.2(r2 =0.98) for 3T3 and the CI50 of Cisplatin were 12.1(r2 = 0.96) for MCF-7; 0.1(r2 = 0.96) for K562 and 0.3(r2 = 0.99) for 3T3. The dose-response relationship of the extract to the 3T3 cell line was -0.98 (p<0.05) and for the K562 tumor cell line was -0.98 (p<0.05). The extract selectivity index were 2.17, 6.07 and 2.39 for the MCF-7, K562 and ME-180 cell lines, respectively; On the contrary, the 5-FU and Cisplatin, only reached values of 0.07 and 0.06; 0.02 and 2.25 for the lines MCF-7 and K562 respectively.   Conclusions: The cytotoxic profile of the Annona cherimola seed etanolic extract is very encouraging by its high citotoxicity against tumor cells and low citotoxicity against normal cells; surpassing, drugs widely known like 5-FU and Cisplatin in selectivity index.

Keywords : Annona cherimola; cytotoxic effect; cancer; medicinal plant.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License